Systemic Hemodynamic Atherothrombotic Syndrome: A New Concept in Cardiovascular Risk Assessment
Jorge Alberto Nuñez-Gamez, MD1, Stefanie Bayona-Gazabón, MD2, Sebastian Villaveces-Buelvas, MD3, Luis Alberto Burgos-de Moya, MD4 and Michael Gregorio Ortega-Sierra, MD5*
1School of Medicine, Universidad del Sinú, Cartagena, Colombia
2School of Medicine, Universidad de Sucre, Sincelejo, Colombia
3School of Medicine, Universidad de Cartagena, Cartagena, Colombia
4School of Medicine, Universidad Simon Bolivar, Barranquilla, Colombia
5Department of Neurosurgery, Universidad Centroccidental Lisandro Alvarado - Hospital Central Antonio María Pineda, Barquisimeto, Venezuela
*Corresponding Author: Michael Gregorio Ortega-Sierra, MD, Department of Neurosurgery, Universidad Centroccidental Lisandro Alvarado - Hospital Central Antonio María Pineda, Barquisimeto, Venezuela.
Received: March 04, 2022 Published: March 16, 2022
To the Editors,
Cardiovascular diseases remain the leading cause of death globally, and one of the major groups of diseases with the highest health care costs in terms of therapy, rehabilitation, disability and incapacity [1]. The burden of disease they generate is worrying, since they occur at increasingly younger ages, which has prompted the development of cardiovascular risk scales and increasingly systematic evaluations to determine the risk of disease and life prognosis in the short-, medium- and long-term [1]. Traditional risk factors, such as diabetes mellitus, arterial hypertension, dyslipidemia, smoking, male sex, among others, and also some non-traditional risk factors such as proteinuria, left ventricular hypertrophy, anemia or prothrombotic states, are commonly used to determine cardiovascular risk in the population [2]. However, evidence-based medicine aims at the continuous identification and assessment of emerging concepts that may impact on the intervention effects of diagnostic methods, therapeutic plans and prognostic tools.
Keywords: Systemic Hemodynamic Atherothrombotic Syndrome, Cardiovascular Diseases, Heart Disease Risk Factors, Arterial Pressure, Blood Pressure
Citation: Nunez-Gamez JA, Bayona-Gazabon S, Villaveces-Buelvas S, Burgos-de Moya LA, Ortega-Sierra MG. “Systemic Hemodynamic Atherothrombotic Syndrome: A New Concept in Cardiovascular Risk Assessment”. SVOA Neurology 3:2 (2022) Pages 66-67.
